SCHEMBL19246798

SCHEMBL19246798

c1ccc(-c2nc(-n3c4ccccc4c4ccc5c(c6ccccc6n5-c5ccccc5)c43)nc3c2oc2ccccc23)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.36
ATM Q13315 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
MAPT P10636 8/20 0.36
TSHR P16473 4/20 0.36
CA12 O43570 1/20 0.34
CA9 Q16790 1/20 0.34
ALDH1A1 P00352 4/20 0.34
LMNA P02545 4/20 0.34
POLB P06746 2/20 0.34
HSD17B10 Q99714 2/20 0.34
HPGD P15428 1/20 0.34
MAPK1 P28482 1/20 0.34
KMT2A Q03164 4/20 0.33
MEN1 O00255 3/20 0.33
ADORA2A P29274 1/20 0.33
PTGER1 P34995 1/20 0.33
CSF1R P07333 1/20 0.33
PDGFRB P09619 1/20 0.33
KIT P10721 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19247088 0.96 MAPT (0.36) KDM4EATML3MBTL1MAPTTSHR
SCHEMBL19247015 0.91 TSHR (0.39) KDM4EATML3MBTL1MAPTTSHR
SCHEMBL18165441 0.91 MAPT (0.39) KDM4EATML3MBTL1MAPTTSHR
SCHEMBL18619452 0.89 MAPT (0.34) KDM4EMAPTTSHRCA12CA9
SCHEMBL19997879 0.89 MAPT (0.38) KDM4EATML3MBTL1MAPTTSHR
SCHEMBL19246810 0.88 MAPT (0.41) KDM4EMAPTTSHRALDH1A1LMNA
SCHEMBL19247092 0.88 MAPT (0.41) KDM4EMAPTTSHRALDH1A1LMNA
SCHEMBL19248073 0.88 MAPT (0.41) KDM4EMAPTTSHRALDH1A1LMNA
SCHEMBL18708374 0.88 MAPT (0.41) KDM4EMAPTTSHRALDH1A1LMNA
SCHEMBL22199816 0.88 MAPT (0.38) KDM4EL3MBTL1MAPTTSHRCA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10873034-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2020-12-22 US disclosed
US-20170237015-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2017-08-17 US disclosed
US-20170237015-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2017-08-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170237015-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CCNA1, ARL1 KDM4E 4143/4885ATM 638/4885L3MBTL1 470/4885
US-10873034-B2 Condensed cyclic compound and organic light-emitting device including the same CRY1, CCNA1, ARL1 KDM4E 4143/4885ATM 638/4885L3MBTL1 470/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.